Alpex Acquisition posts $924K in Q3 2026 net income
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Alpex Acquisition Corp (ALPX), a special purpose acquisition company, reported third-quarter net income of $924,086, although it had not generated operating revenue or completed a business combination as of September 30, 2026. Trust investments generated $1,038,267 of the quarter’s income, compared with $118,072 in operating expenses; net income therefore reflected trust earnings rather than operating revenue.
At September 30, ALPX held $282,656 in cash outside its restricted Trust Account, which held $116,070,637. Current liabilities were $226,653, and $805,000 of deferred underwriting fees is payable from the Trust Account upon a business combination. Management said substantial doubt exists about its ability to continue as a going concern for one year after issuance; its plans do not alleviate that doubt. The company must complete a business combination by June 26, 2027, unless extended under its governing documents.
In November 2026, ALPX entered a non-binding letter of intent with a prospective target; the proposal remains subject to due diligence, negotiations, definitive agreements and applicable approvals. The company’s disclosure controls and procedures were not effective as of September 30, 2026.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointManagement disclosed substantial doubt about going concern for one year after issuance.
Filing Explained
The advisory agreement sets fees of eight hundred thousand dollars; seventy-five thousand dollars was paid by September thirtieth, with remaining advisory payments tied to milestones.
At
Each right entitles its holder to one-fourth of a Class A share upon a qualifying combination; each whole warrant entitles its holder to one Class A share at
The de-SPAC advisory engagement provides for aggregate fees of
If no combination closes by
Key Figures
Key Terms
going concern financial
temporary equity financial
two-class method financial
deferred underwriting commission financial
Level 1 inputs financial
Working Capital Loans financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was ALPX’s net income for the third quarter of 2026?
How much cash did ALPX have outside its Trust Account?
What is the status of ALPX’s potential business combination?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For the quarterly period ended
For the transition period from _________ to __________
Commission File Number
(Exact name of registrant as specified in its charter)
| N/A | ||
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| ☒ | Smaller reporting company | ||
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of November 20, 2026, there were
Alpex Acquisition Corporation
TABLE OF CONTENTS
| PART I – FINANCIAL INFORMATION | 1 |
| Item 1. FINANCIAL STATEMENTS (UNAUDITED) | 1 |
| Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 13 |
| Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 15 |
| Item 4. CONTROLS AND PROCEDURES | 15 |
| PART II – OTHER INFORMATION | 16 |
| Item 1. LEGAL PROCEEDINGS | 16 |
| Item 1A. RISK FACTORS | 16 |
| Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS FROM REGISTERED SECURITIES | 16 |
| Item 3. DEFAULTS UPON SENIOR SECURITIES | 16 |
| Item 4. MINE SAFETY DISCLOSURES | 16 |
| Item 5. OTHER INFORMATION | 16 |
| Item 6. EXHIBITS | 16 |
| SIGNATURES | 17 |
i
PART I – FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
ALPEX ACQUISITION CORPORATION
UNAUDITED CONDENSED BALANCE SHEET
September 30, 2026 (Unaudited)
| September 30, 2026 |
||||
| ASSETS | ||||
| Current assets | ||||
| Cash and cash equivalents | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Cash and marketable securities held in trust account | ||||
| Total assets | ||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | ||||
| Current liabilities | ||||
| Accrued expenses and other current liabilities | ||||
| Promissory note – related party | ||||
| Total current liabilities | ||||
| Deferred underwriting fee payable | ||||
| Total liabilities | ||||
| Commitments and contingencies (Note 6) | ||||
| Class A ordinary shares subject to possible redemption, $ | ||||
| Shareholders’ deficit | ||||
| Preference shares, $ | - | |||
| Class A ordinary shares, $ | ||||
| Class B ordinary shares, $ | ||||
| Additional paid-in capital | - | |||
| Accumulated deficit | ( | ) | ||
| Total shareholders’ deficit | ( | ) | ||
| Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ deficit | ||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
1
ALPEX ACQUISITION CORPORATION
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
Amounts in U.S. dollars, except shares and per-share data
| Three months ended September 30, 2026 |
January 5, 2026 (inception) through September 30, 2026 |
|||||||
| Formation and operating costs | ( | ) | ( | ) | ||||
| Share-based compensation | - | ( | ) | |||||
| Total Operating Loss | ( | ) | ( | ) | ||||
| Interest income on cash and cash equivalents | ||||||||
| Interest income on marketable securities held in trust account | ||||||||
| Net income | ||||||||
| Basic and diluted weighted-average shares outstanding, Class A ordinary shares subject to possible redemption | ||||||||
| Basic net income per share, Class A ordinary shares subject to possible redemption | $ | $ | ||||||
| Diluted net income per share, Class A ordinary shares subject to possible redemption | $ | $ | ||||||
| Basic and diluted weighted-average shares outstanding, non-redeemable Class A ordinary shares | ||||||||
| Basic net income per share, non-redeemable Class A ordinary shares | $ | $ | ||||||
| Diluted net income per share, non-redeemable Class A ordinary shares | $ | $ | ||||||
| Basic weighted-average shares outstanding, non-redeemable Class B ordinary shares (1) | ||||||||
| Basic net income per share, non-redeemable Class B ordinary shares | $ | $ | ||||||
| Diluted weighted-average shares outstanding, non-redeemable Class B ordinary shares | ||||||||
| Diluted net income per share, non-redeemable Class B ordinary shares | $ | $ | ||||||
| (1) |
The accompanying notes are an integral part of these unaudited condensed financial statements.
2
ALPEX ACQUISITION CORPORATION
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT
January 5, 2026 (inception) through September 30, 2026
| Ordinary shares | Additional | Share | Total | |||||||||||||||||||||||||||||
| Class A | Class B | Paid-in | Accumulated | subscription | Shareholders’ | |||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Capital | deficit | Receivable | deficit | |||||||||||||||||||||||||
| Balance, January 5, 2026 (inception) | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||
| Class B ordinary shares issued to Sponsor | - | - | - | ( | ) | - | ||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | ( | ) | - | ( | ) | ||||||||||||||||||||||
| Balance as of March 31, 2026 | - | - | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||
| Net loss | - | - | - | - | - | ( | ) | - | ( | ) | ||||||||||||||||||||||
| Issuance of representative shares | - | - | - | - | ||||||||||||||||||||||||||||
| Sales of private placement units | - | - | - | - | ||||||||||||||||||||||||||||
| Issuance of Public Rights | - | - | - | - | - | - | ||||||||||||||||||||||||||
| Issuance of Public Warrants | - | - | - | - | - | - | ||||||||||||||||||||||||||
| Offering costs allocated to equity-classified instruments | - | - | - | - | ( | ) | - | - | ( | ) | ||||||||||||||||||||||
| Capital contribution from Sponsor | - | - | - | - | - | - | ||||||||||||||||||||||||||
| Accretion of Class A ordinary shares subject to possible redemption to initial redemption value | - | - | - | - | ( | ) | - | - | ( | ) | ||||||||||||||||||||||
| Remeasurement of Class A ordinary shares subject to possible redemption for Trust Account earnings | - | - | - | - | ( | ) | - | - | ( | ) | ||||||||||||||||||||||
| Collection of share capital receivable | - | - | - | - | - | - | ||||||||||||||||||||||||||
| Sponsor contribution for director services | - | - | - | - | - | - | ||||||||||||||||||||||||||
| Balance as of June 30, 2026 | ( | ) | - | ( | ) | |||||||||||||||||||||||||||
| Redemption-value adjustment | - | - | - | - | ( | ) | ( | ) | - | ( | ) | |||||||||||||||||||||
| Net income | - | - | - | - | - | - | ||||||||||||||||||||||||||
| Balance as of September 30, 2026 | - | ( | ) | - | ( | ) | ||||||||||||||||||||||||||
Class A share counts above exclude
The accompanying notes are an integral part of these unaudited condensed financial statements.
3
ALPEX ACQUISITION CORPORATION
UNAUDITED CONDENSED STATEMENT OF CASH FLOWS
January 5, 2026 (inception) through September 30, 2026
| Amount | ||||
| Cash Flows from Operating Activities: | ||||
| Net income | ||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||
| Formation and operating costs paid by Sponsor | ||||
| Deferred offering cost written off to expense | ||||
| Income earned on investments held in the Trust Account | ( | ) | ||
| Noncash share-based compensation | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses | ( | ) | ||
| Accrued liabilities and other payables | ||||
| Net cash used in operating activities | ( | ) | ||
| Cash Flows from Investing Activities: | ||||
| Cash invested in trust account | ( | ) | ||
| Net cash used in investing activities | ( | ) | ||
| Cash Flows from Financing Activities: | ||||
| Sponsor cash contribution | ||||
| Gross proceeds from IPO | ||||
| Cash proceeds from private placement | ||||
| Offering costs paid | ( | ) | ||
| Net cash provided by financing activities | ||||
| Net increase in cash and cash equivalents | ||||
| Cash and cash equivalents at beginning of period | - | |||
| Cash and cash equivalents at end of period | ||||
| Supplemental disclosure of non-cash financing activities: | ||||
| Deferred offering costs paid by Sponsor and included in Promissory Note | ||||
| Deferred underwriting fee accrued and charged to additional paid-in capital | ||||
| Private placement and founder share subscription amounts settled against Promissory Note | ||||
| Representative shares issued as non-cash underwriting compensation | ||||
| Sponsor contribution through share-based compensation | ||||
| Promissory Note reclassified to accrued compensation | ||||
| Trust-earnings redemption-value accretion | ||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
4
ALPEX ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
September 30, 2026
NOTE 1 ORGANIZATION OPERATIONS AND GOING CONCERN
Alpex Acquisition Corporation (the “Company”) was incorporated in the Cayman Islands on
On June 26, 2026, the Company completed its initial public offering (the “Initial Public Offering”) of
Following the closing of the Initial Public Offering, $
The Company must complete a Business Combination by June 26, 2027, unless the period is extended in accordance with its governing documents. If the Company is unable to complete a Business Combination within the applicable period, it will cease operations except for the purpose of winding up, redeem the Public Shares using the funds then held in the Trust Account, including interest earned thereon, net of taxes payable and permitted dissolution expenses, and thereafter liquidate, subject to applicable law and the Company’s obligations to creditors.
The Sponsor and the Company’s officers and directors have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares and the Class A ordinary shares included in the Private Placement Units if the Company does not complete a Business Combination within the applicable period. Such waiver does not apply to any Public Shares that the Sponsor, officers or directors may acquire, with respect to which they retain the applicable redemption rights.
As described in the IPO prospectus, the Sponsor agreed to indemnify the Company for certain claims that reduce the funds held in the Trust Account, subject to the applicable limitations and exceptions.
As of September 30, 2026, the Company had $
The funds held in the Trust Account are restricted and are generally unavailable to fund the Company’s ordinary operating expenses. The Company expects to continue incurring significant costs in identifying, evaluating and completing a Business Combination and in meeting its public company reporting and compliance obligations.
Management may seek additional financing from the Sponsor or third parties, including through working capital loans. However, there can be no assurance that such financing will be available when needed or that the Company will complete a Business Combination within the required period.
Management concluded that substantial doubt exists about the Company’s ability to continue as a going concern for one year after the date these unaudited condensed financial statements are issued. Management’s plans do not alleviate the substantial doubt. Accordingly, the accompanying financial statements have been prepared on a going-concern basis and do not include any adjustments that might result from the outcome of this uncertainty.
5
ALPEX ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
September 30, 2026
NOTE 2 SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). The financial information provided is unaudited but includes all adjustments which management considers necessary for the fair presentation of the results for the period.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The Company has elected to use the extended transition period for complying with new or revised accounting standards under Section 107(b) of the JOBS Act.
Accordingly, the Company may adopt new or revised accounting standards at the effective dates applicable to private companies when those dates differ from the effective dates applicable to public business entities. As a result, the Company’s financial statements may not be comparable to those of public companies that have not elected to use the extended transition period.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the financial statement date, and the reported amounts of expenses and other income during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents were $
Cash and marketable securities held in Trust Account
As of September 30, 2026, substantially all of the assets held in the Trust Account were held in a money market fund that invests solely in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from changes in the fair value of investments held in the Trust Account are included in investment income earned on marketable securities held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. The Company had $
Offering Costs Associated with the Initial Public Offering
The Company accounts for offering costs in accordance with ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5.A, “Expenses of Offering.” These costs consist principally of professional and registration fees directly attributable to the Initial Public Offering. The Company allocated the proceeds from the Units using the residual method under ASC 470-20. Proceeds were allocated first to the assigned values of the warrants and rights, with the remainder allocated to the Class A ordinary shares.
Offering costs attributable to the Public Shares were charged to temporary equity. Costs attributable to the warrants and rights included in the Units, the Private Placement Units and the Representative Shares were charged to shareholders’ deficit. The Company accounts for the Public and Private Placement Rights under ASC 815 and the Public and Private Placement Warrants under ASC 815-40. The rights and warrants qualify for equity classification, were recorded at their assigned values upon issuance and are not subsequently remeasured.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $
6
ALPEX ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
September 30, 2026
NOTE 2 SIGNIFICANT ACCOUNTING POLICIES CONTINUED
Class A Ordinary Shares Subject to Possible Redemption
Public Class A shares are presented in temporary equity because their redemption is outside the Company’s sole control. The Company adjusts them to the applicable redemption value, charging available APIC and then accumulated deficit. Such adjustments do not enter net income. Public and private rights and warrants remain equity-classified under the Company’s instrument-specific ASC 815-40 assessment and are not subsequently marked to market.
Share-based compensation
Equity awards provided by a shareholder for services to the Company are recognized under ASC 718 as compensation expense and a capital contribution. Compensation reflects grant-date fair value less consideration paid by the service provider. The independent-director award is described in Note 5.
Income Tax
The Company accounts for income taxes under ASC 740. The Company is not subject to income tax in the Cayman Islands and had no taxable nexus in another jurisdiction during the periods presented. Accordingly, no income tax expense was recognized. ASU 2023-07 was adopted at formation. Management does not expect any recently issued accounting standards not yet adopted to have a material effect on the Company’s financial statements.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
| ● | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; | |
| ● | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and | |
| ● | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Fair Value of Financial Instruments
The carrying amounts of the Company’s financial assets and liabilities, other than investments held in the Trust Account, approximate their fair values primarily due to their short-term nature. Investments held in the Trust Account are measured at fair value on a recurring basis.
Net Income Per Ordinary Share
The Company has two classes of ordinary shares, Class A ordinary shares and Class B ordinary shares. Under the two-class method, net income is allocated pro rata among redeemable Class A ordinary shares, non-redeemable Class A ordinary shares and Class B ordinary shares. Net income per ordinary share is calculated by dividing the income allocated to each group by its weighted-average shares outstanding for the period. Accretion and remeasurement of Class A ordinary shares subject to possible redemption are excluded from the earnings-per-share calculation because their redemption value approximates fair value.
The forfeiture condition on
The public and private placement rights and warrants were excluded from diluted earnings per share because the initial Business Combination had not been completed as of September 30, 2026. The rights represented
7
ALPEX ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
September 30, 2026
The following tables reconcile the numerators and denominators used to calculate basic and diluted net income per ordinary share.
| Three Months Ended | ||||||||||||
| September 30, 2026 | ||||||||||||
| Class A Redeemable | Class A Non-redeemable | Class B Non-redeemable | ||||||||||
| Basic net income per ordinary share: | ||||||||||||
| Numerator: | ||||||||||||
| Allocation of net income, basic | $ | $ | $ | |||||||||
| Denominator: | ||||||||||||
| Basic weighted-average ordinary shares outstanding | ||||||||||||
| Basic net income per ordinary share | $ | $ | $ | |||||||||
| Diluted net income per ordinary share: | ||||||||||||
| Numerator: | ||||||||||||
| Allocation of net income, diluted | $ | $ | $ | |||||||||
| Denominator: | ||||||||||||
| Diluted weighted average ordinary shares outstanding | ||||||||||||
| Diluted net income per ordinary share | $ | $ | $ | |||||||||
For the Period from January 5, 2026 (inception) through | ||||||||||||
| September 30, 2026 | ||||||||||||
| Class A Redeemable | Class A Non-redeemable | Class B Non-redeemable | ||||||||||
| Basic net income per ordinary share: | ||||||||||||
| Numerator: | ||||||||||||
| Allocation of net income, basic | $ | $ | $ | |||||||||
| Denominator: | ||||||||||||
| Basic weighted average ordinary shares outstanding | ||||||||||||
| Basic net income per ordinary share | $ | $ | $ | |||||||||
| Diluted net income per ordinary share: | ||||||||||||
| Numerator: | ||||||||||||
| Allocation of net income, diluted | $ | $ | $ | |||||||||
| Denominator: | ||||||||||||
| Diluted weighted average ordinary shares outstanding | ||||||||||||
| Diluted net income per ordinary share | $ | $ | $ | |||||||||
Recent Accounting Pronouncements
In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which expands annual and interim disclosures regarding significant segment expenses, other segment items and the role of the chief operating decision maker. The Company adopted ASU 2023-07 upon incorporation. The adoption resulted in additional disclosures and did not have a material effect on the Company’s financial statements.
In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” and in January 2025 issued ASU 2025-01 to clarify the effective date. The guidance requires additional disclosures about the nature of expenses included in income statement captions. The guidance is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027, with early adoption permitted. The Company is evaluating the impact of the guidance and does not expect adoption to have a material effect on its financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards would have a material effect on the Company’s financial statements if adopted currently.
8
ALPEX ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
September 30, 2026
NOTE 3 INITIAL PUBLIC OFFERING
On June 26, 2026, the Company completed its Initial Public Offering of
Each whole warrant entitles the holder to purchase one Class A ordinary share at $
NOTE 4 PRIVATE PLACEMENT
At the IPO closing, Hugreat Ltd, the Company’s Sponsor, purchased
NOTE 5 RELATED PARTY TRANSACTIONS AND DIRECTOR SHARE COMPENSATION
Founder shares and independent-director awards
The Sponsor’s Founder Share purchase comprised
The Sponsor transferred
Promissory Note - Related Party and executive compensation
The balance of the promissory note payable to the Sponsor (the “Promissory Note”) at September 30, 2026 was $
CEO and CFO compensation was limited to six months of monthly payments of $
Working capital loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”), with the aggregate principal amount capped at $
9
ALPEX ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
September 30, 2026
NOTE 6 COMMITMENTS AND CONTINGENCIES
Underwriting and registration arrangements
The Company paid a cash underwriting commission of $
During September 2026, the Company paid $
NOTE 7 SHAREHOLDERS’ DEFICIT AND REDEEMABLE SHARES
The authorized capital comprises
| Redeemable Class A carrying amount | Amount | |||
| Balance, June 30, 2026 | ||||
| Trust-earnings redemption-value increase in Q3 | ||||
| Balance, September 30, 2026 | ||||
Of the quarter’s $
Warrants and rights
At September 30, 2026,
The
10
ALPEX ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
September 30, 2026
NOTE 8 FAIR VALUE MEASUREMENTS
The Trust Account is invested in quoted money market fund holdings measured using Level 1 inputs. Its September 30, 2026 fair value was $
| Recurring fair-value asset | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
| Trust investments | - | - | ||||||||||||||
The carrying amount of accrued payables approximates fair value due to their short-term nature.
NOTE 9 SEGMENT INFORMATION
ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.
The Company’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has
| For the three months ended September 30, 2026 | For the period from January 5, 2026 (inception) through September 30, 2026 | |||||||
| Formation and operating costs | $ | $ | ||||||
| Loss from operations | ( | ) | ( | ) | ||||
| Interest income on cash and cash equivalents | ||||||||
| Interest income on marketable securities held in trust account | ||||||||
| Total other income | ||||||||
| Net income | $ | $ | ||||||
11
ALPEX ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
September 30, 2026
| As of September 30, 2026 | ||||
| Cash and marketable securities held in trust account | $ | |||
The CODM reviews income earned on the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.
Formation and operating costs are reviewed and monitored by the CODM to manage and forecast cash to ensure that enough capital is available to complete a Business Combination or similar transaction within the Business Combination period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Formation and operating costs, as reported on the accompanying unaudited statements of operations, are the significant segment expenses provided to the CODM on a regular basis.
All other segment items included in net loss are reported on the accompanying unaudited statements of operations and described within their respective disclosures.
NOTE 10 SUBSEQUENT EVENTS
The Company evaluated subsequent events through November 20, 2026, the date these financial statements were issued.
In November 2026, the Company entered into a non-binding letter of intent with a prospective target regarding a potential business combination. The letter of intent includes certain binding provisions relating to confidentiality, exclusivity and expenses. The proposed transaction remains subject to due diligence, negotiation and execution of definitive agreements, and applicable approvals. There can be no assurance that a definitive agreement will be executed or that the proposed transaction will be completed. The financial effect of the proposed business combination cannot be reasonably estimated at this time.
12
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This discussion should be read together with the unaudited condensed financial statements and accompanying notes in Item 1. Forward-looking statements involve uncertainty; transaction timing, financing and future costs may differ from current expectations.
Overview
We are a Cayman Islands special purpose acquisition company formed on January 5, 2026. We completed our IPO on June 26, 2026 and are pursuing an initial business combination. We had not completed a business combination or generated operating revenue at September 30, 2026. Our activities include evaluating opportunities, engaging advisers and satisfying our public-company obligations. Our fiscal year ends December 31.
Each IPO unit included a Class A share, a warrant and a right to one-fourth of a Class A share. The IPO raised $115.0 million, and the Sponsor’s concurrent private placement provided $1.8 million cash and a $75,000 noncash offset. We initially funded the Trust Account with $115.0 million. We must complete a business combination by June 26, 2027 unless the period is validly extended.
Results of operations
| Three months ended September 30, 2026 | January 5, 2026 (inception) through September 30, 2026 | |||||||
| Formation and operating costs | 118,072 | 334,956 | ||||||
| Share-based compensation | - | 64,401 | ||||||
| Total operating expenses | 118,072 | 399,357 | ||||||
| Operating-account interest income | 3,890 | 5,160 | ||||||
| Income earned on investments held in the Trust Account | 1,038,267 | 1,070,637 | ||||||
| Net income | 924,086 | 676,441 | ||||||
For the three months ended September 30, 2026, net income was $924,086. Investment and interest income of $1,042,157 exceeded operating expenses of $118,072. Trust income contributed $1,038,267 and operating-account interest contributed $3,890. Operating expenses included $30,000 of D&O insurance expense, $30,000 of accounting and audit fees, $9,166 of executive compensation, $22,215 of professional fees and $26,690 of other G&A costs.
For the period from January 5, 2026 (inception) through September 30, 2026, net income was $676,441, reflecting $1,075,797 of interest and investment income and $399,357 of operating expenses. Costs included Company formation, IPO readiness, Nasdaq listing, audit and accounting services, executive compensation, insurance, professional services and the director award. No comparable 2025 period exists because the Company was formed in 2026.
The positive net income primarily reflects restricted trust investment earnings. It is not operating revenue, and it does not indicate that unrestricted cash increased. The $1,038,267 quarter-end increase in the redemption value of public shares was recorded in equity and did not reduce net income. The $64,401 director award was a noncash expense and Sponsor contribution; it did not issue new shares or consume Company cash.
13
Liquidity and capital resources
At September 30, 2026, we had $282,656 of cash outside trust, $466,781 of prepaid expenses, including $291,781 of prepaid financial-advisory services. The Trust Account held $116,070,637, consisting of the initial deposit and reinvested earnings. Trust principal is restricted and is not available to meet ordinary operating expenditures. Current liabilities were $226,653, including $209,653 due under the Promissory Note and $17,000 of accrued expenses. A further $805,000 of deferred underwriting compensation is payable upon a business combination under the existing agreement.
| January 5, 2026 (inception) through September 30, 2026 | Cash flow | |||
| Operating activities | (691,026 | ) | ||
| Investing activities | (115,000,000 | ) | ||
| Financing activities | 115,973,682 | |||
| Net increase in cash | 282,656 | |||
Net cash used in operating activities was $691,026. Net income of $676,441 was adjusted for $1,070,637 of trust income retained in trust, $92,925 of costs paid directly by the Sponsor, $5,000 of deferred offering costs written off and $64,401 of noncash share compensation. Operating asset and liability changes used a net $459,156, comprising $466,781 of prepaid expenses, partially offset by $7,625 of adjusted accrued-liability changes. The $9,375 Promissory Note reclassification was excluded from cash flows.
Investing cash outflows were $115,000,000 for the initial Trust Account funding. Financing inflows of $115,973,682 comprised $115,000,000 of public offering receipts, $1,800,000 of private placement cash and a $1,000 Sponsor contribution, less $827,318 of offering costs paid. The $75,000 private placement offset, $25,000 founder subscription offset, deferred underwriting commission and representative-share compensation were noncash items.
During the third quarter, significant cash uses included a $300,000 financial advisory payment and a $75,000 initial payment under the legal engagement letter. The unconsumed portions of both payments are included in prepaid expenses. Advisory expense of $8,219 was recognized for September 21–30, 2026. We expect to incur further advisory and legal costs while pursuing a business combination. Prepaid advisory and legal fees are recognized as expenses as the related services are received.
Going concern and financing plans
Our available operating cash is limited compared with the costs of evaluating and completing a transaction and meeting public-company obligations. We may seek Sponsor or third-party financing, but no potential source should be treated as assured without a commitment. The business-combination deadline and liquidity conditions raise substantial doubt about our ability to continue as a going concern for one year after issuance. Failure to obtain funding or complete a transaction could require us to curtail activities and ultimately redeem the public shares and liquidate. See Note 1 for management’s assessment and plans.
Commitments and critical accounting judgments
Our significant arrangements include the deferred underwriting commission, the Promissory Note, advisory and legal engagements and the IPO registration-rights and indemnification arrangements. Notes 5 through 7 describe their accounting and outstanding balances.
Significant judgments include the classification and redemption measurement of public shares; allocation of IPO proceeds and issuance costs; equity classification of rights and warrants; valuation of the independent-director shares; service-period recognition and recoverability of prepaid advisory fees; and earnings per share. The independent-director measurement uses an estimated transaction probability and marketability adjustment. Changes in relevant assumptions could affect the measurement; the recorded equity-classified award is not subsequently remeasured solely for changes in the share price.
We do not currently have operating revenue. The CODM monitors the cash position, trust earnings and transaction-related expenditures within a single reportable segment. Additional segment information and the current significant expenses are included in Note 9.
14
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are not required to provide the information otherwise required under this item.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to provide reasonable assurance that information required in reports filed under the Exchange Act is recorded, processed, summarized and reported within the SEC’s prescribed time periods and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to permit timely disclosure decisions. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2026 pursuant to Rule 13a-15(b) under the Exchange Act. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30, 2026.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
This Quarterly Report does not include an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.
Changes in Internal Control Over Financial Reporting
During the quarter ended September 30, 2026, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
15
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
We are not a party to any material legal proceedings and no material legal proceedings have been threatened by us or, to the best of our knowledge, against us.
ITEM 1A. RISK FACTORS.
As a smaller reporting company, we are not required to include risk factors in this Quarterly Report. However, factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in the prospectus related to the IPO (File No. 333-294978) (the “Prospectus”). Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in the Prospectus.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS FROM REGISTERED SECURITIES.
There were no unregistered sales of equity securities by the Company during the quarter ended September 30, 2026. The IPO closed on June 26, 2026. The use of IPO and private placement proceeds, including the $115,000,000 initially deposited in the Trust Account, is discussed in Item 2 of Part I under Liquidity and Capital Resources.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4. MINE SAFETY DISCLOSURES.
Not applicable.
ITEM 5. OTHER INFORMATION.
ITEM 6. EXHIBITS
The exhibits below are filed, furnished or incorporated by reference with this report.
| Exhibit No. | Description | |
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 32.2** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS* | Inline XBRL Instance Document | |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document | |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104* | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| * | Filed herewith |
| ** | Furnished. |
16
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Alpex Acquisition Corporation | ||
| Date: November 20, 2026 | By: | /s/ Xiaolin Zheng |
| Xiaolin Zheng | ||
| Chief Executive Officer (Principal Executive Officer) | ||
| Date: November 20, 2026 | By: | /s/ Ying Xu |
| Ying Xu | ||
| Chief Financial Officer (Principal Financial Officer) | ||
17